Catalyst Wire Dossier Catalyst Wire Dossier

AC2993

AC2993 · AstraZeneca
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for AC2993, covering 2013-07-31 to 2015-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes [Phase 2]

See pricing